首页> 外文期刊>Molecular medicine reports >Effects of tanshinone IIA on fibrosis in a rat model of cirrhosis through heme oxygenase-1, inflammation, oxidative stress and apoptosis
【24h】

Effects of tanshinone IIA on fibrosis in a rat model of cirrhosis through heme oxygenase-1, inflammation, oxidative stress and apoptosis

机译:丹参酮IIA对血红素氧酶-1,炎症,氧化应激和凋亡肝硬化大鼠纤维化纤维化的影响

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Tanshinone IIA is extracted from the root of Salvia miltiorrhiza and used in traditional Chinese medicine for its anti-inflammatory activity and antioxidant effects. The aim of the present study was to investigate the potential protective effects of tanshinone IIA against fibrosis in a rat model of cirrhosis and to elucidate the underlying mechanisms. Male Sprague Dawley rats were used as the model of cirrhosis in the present study. In the cirrhotic rats, the extent of fibrosis, levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), heme oxygenase-1 (HO-1) protein expression, serum levels of nuclear factor (NF)-kappa B, tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1 beta and IL-6, superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-PX), and the protein expression levels of phosphorylated-p38 mitogen-activated protein kinase (MAPK) were all significantly increased. However, the serum malondialdehyde (MDA) activity and protein kinase B (Akt) protein expression were suppressed in cirrhotic rats compared with the sham (control) group. Compared with the cirrhotic group, administration of tanshinone IIA reduced the extent of fibrosis, levels of ALT and AST, HO-1 protein expression, serum NF-kappa B, TNF-alpha, IL-1 beta and IL-6 levels, and the activity of SOD, CAT and GSH-PX. Furthermore, administration of tanshinone IIA significantly increased the inhibition of the serum MDA activity and the Akt protein expression in cirrhotic rats compared with those in the cirrhotic group. The protective effect of tanshinone IIA suppresses fibrosis in a rat model of cirrhosis, and reduces inflammation and oxidative stress, via the HO-1, Akt and p38 MAPK signaling pathway.
机译:丹参酮IIa是从丹参根的根系中提取,用于中药用于其抗炎活动和抗氧化作用。本研究的目的是探讨丹参酮IIA对肝硬化大鼠模型中纤维化的潜在保护作用,并阐明潜在机制。男性Sprague Dawley大鼠被用作本研究中的肝硬化模型。在肝硬化大鼠中,纤维化程度,丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST),血红素氧酶-1(HO-1)蛋白表达,血清核因子(NF)-Kappa B,肿瘤坏死因子 - α(TNF-α),白细胞介素(IL)-1β和IL-6,超氧化物歧化酶(SOD),过氧化氢酶和谷胱甘肽过氧化物酶(GSH-PX),以及磷酸化-P38丝裂原的蛋白表达水平 - 活化的蛋白激酶(MAPK)都显着增加。然而,与假(对照)组相比,在肝硬化大鼠中抑制了血清丙炔醛(MDA)活性和蛋白激酶B(AKT)蛋白表达。与肝硬化群体相比,丹参酮IIA的施用降低了纤维化,ALT和AST水平,HO-1蛋白表达,血清NF-Kappa B,TNF-α,IL-1β和IL-6水平的程度SOD,CAT和GSH-PX的活性。此外,与肝硬化组中的施用丹参酮IIA的施用显着增加血清MDA活性的抑制和肝硬化大鼠中的AKT蛋白表达。丹参酮IIA的保护作用抑制了肝硬化大鼠模型中纤维化,通过HO-1,AKT和P38 MAPK信号通路降低炎症和氧化应激。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号